4Salvesen R,Eldoen G.Treatment of cerebral infarction at the stroke unit in Bodo 2011-12 [ J ].Tidsskr Nor Laegeforen, 2013, 133(17) : 1824-1827.
5Fischer U,Arnold M,Nedeltchev K,et al.NIHSS score and arteriographie findings in acute ischemic stroke [J].Stroke,2005, 36(10) : 2121-2125.
6An SA,Lee HB,Kim Y,et al.Plasma total homocysteine level is associated with the pulsatility index of cerebral arteries in lacunar infarction [ J ].Yonsei Med J, 2013,54 (4) : 819-824.
7Ikeda S,Harada K,Ohwatashi A,et al.Effects of edaravone,a free radical scavenger,on photochemicallyinduced cerebral infarction in a rat hemiplegic model[J].Scientific World Journal, 2013,2013 : 175280.
8Shinohara Y, Inoue S.Cost-effectiveness analysis of the neuroprotective agent edaravone for noncardioembolie cerebral infarction [J].J Stroke Cerebrovasc Dis, 2013,22(5):668-674.
9Kikuchi K, Kawahara KI, Uchikado H, et al.Potential of edaravone for neuroprotection in neurologic diseases that do not involve cerebral infarction[J].Exp Ther Med,2011,2(5) :771- 775.
10Higashi Y.Edaravone for the treatment of acute cerebral infarction:role of endothelium-derived nitric oxide and oxidative stress [ J ].Expert Opin Pharmacother, 2009,10 (2) : 323-331.
